Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients

Long COVID: major findings, mechanisms and recommendations

(2023) Hannah E. Davis et al.   NATURE REVIEWS MICROBIOLOGY

Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study

(2023) Renin Chang et al.   EClinicalMedicine

Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae

(2022) Yapeng Su et al.   CELL

Early clues regarding the pathogenesis of long-COVID

(2022) Michael J. Peluso et al.   TRENDS IN IMMUNOLOGY

Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection

(2022) Michael J. Peluso et al.   AIDS

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021

(2022) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dysregulated naive B cells and de novo autoreactivity in severe COVID-19

(2022) Matthew C. Woodruff et al.   NATURE

Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq

(2022) Sara E Vazquez et al.   eLife

NFKB2 haploinsufficiency identified via screening for IFNα2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications

(2022) Aaron Bodansky et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma

(2021) Sara E. Vazquez et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Post-acute COVID-19 syndrome

(2021) Ani Nalbandian et al.   NATURE MEDICINE

Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study

(2021) Jessica Seeßle et al.   CLINICAL INFECTIOUS DISEASES

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

(2021) Monique G. P. van der Wijst et al.   Science Translational Medicine

New-onset IgG autoantibodies in hospitalized patients with COVID-19

(2021) Sarah Esther Chang et al.   Nature Communications

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

(2021) Amy D. Proal et al.   Frontiers in Microbiology

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

(2021) Paul Bastard et al.   Science Immunology

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

(2021) Michael J Peluso et al.   CLINICAL INFECTIOUS DISEASES

Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement

(2021) Michael J Peluso et al.   Open Forum Infectious Diseases

Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions

(2021) Michael J. Peluso et al.   Translational Research

Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq

(2020) Sara E Vazquez et al.   eLife

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

(2020) Paul Bastard et al.   SCIENCE

Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis

(2019) Caleigh Mandel-Brehm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autoantigen discovery with a synthetic human peptidome

(2011) H Benjamin Larman et al.   NATURE BIOTECHNOLOGY